Fumonisin B1 exposure induces cardiac inflammation in C57BL/6 mice

Selwyn Gounder1, Ndumiso Mhlongo1, Terisha Ghazi1

  • 1Discipline of Medical Biochemistry, School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

Archives of Toxicology
|March 31, 2026
PubMed

Insights

Fumonisin B1 (FB1) mycotoxin exposure in mice causes significant cardiac inflammation and epigenetic changes, increasing DNA methylation and impacting key inflammatory pathways, leading to heart distress.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Mycotoxin toxicity, particularly fumonisin B1 (FB1), presents serious health risks and is linked to various diseases.
  • FB1 is known to disrupt sphingolipid biosynthesis, induce oxidative stress, apoptosis, mitochondrial dysfunction, and inflammation.

Purpose of the Study:

  • To investigate the effects of acute FB1 exposure on cardiac inflammation and epigenetic modifications in C57BL/6 mice.
  • To explore potential molecular interactions between FB1 and key inflammatory proteins.

Main Methods:

  • Molecular docking was used to predict FB1 interactions with TNF-α, iNOS, NF-κB p65, and NF-κB p50.
  • Analysis of cardiac tissue included gene expression (qPCR), protein expression (Western blotting), nitric oxide levels, cytokine levels (ELISA), and global DNA methylation (ELISA).

Main Results:

  • Molecular docking indicated FB1 interacts with TNF-α, iNOS, and NF-κB.
  • FB1 exposure significantly altered the expression of inflammatory cytokines and DNA methylation-related genes.
  • Increased pro-inflammatory cytokine and global DNA methylation levels, including DNMT1 upregulation, were observed.

Conclusions:

  • Acute FB1 exposure in mice induces significant cardiac inflammation and epigenetic alterations.
  • These changes disrupt inflammatory and DNA methylation pathways, potentially contributing to cardiac complications.

Related Concept Videos